|
|
LaGray is the first vertically integrated
pharmaceutical manufacturing company in West Africa. We
produce both active pharmaceutical
ingredients (APIs) and finished dosage
forms. We are the first manufacturer
of APIs in West Africa. Vertical integration
gives us control over quality from start to
finish. |
|
Our focus is on drugs for treating
respiratory tract infections,
HIV-AIDS, opportunistic infections, malaria,
and tuberculosis. Other targeted
areas are parasitic, bacterial and
fungal infections as well as
dermatological diseases commonly found in
the tropics. |
|
 |
|
| |
|
|
- Fully integrated
manufacture of active pharmaceutical ingredients and
formulations
-
Compliant with
international standards of Good Manufacturing
Practices for pharmaceuticals
-
Production of critical branded generic and voluntarily
licensed drugs
-
Focus on critical
needs for saving lives and improving the quality of
life in Africa
-
A partner
in the fight to against the vicious
cycle of poverty and disease in Africa
|
|
>70% of mortality
in sub-Saharan Africa is due to disease.
Disease also contributes to massive economic losses
in the region.
Effective drugs
exist for treating most of these diseases, the
issue is affordability and availability. We
are poised and striving to make a
difference.
Our current range of
products includes dermatologicals,
oral antiinfectives and antiinfective bulk
drugs.
Learn more>> |
|
